Marco Cipolli

4.7k total citations · 1 hit paper
94 papers, 2.8k citations indexed

About

Marco Cipolli is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Marco Cipolli has authored 94 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 42 papers in Pulmonary and Respiratory Medicine and 38 papers in Immunology. Recurrent topics in Marco Cipolli's work include Blood disorders and treatments (41 papers), Cystic Fibrosis Research Advances (39 papers) and Immunodeficiency and Autoimmune Disorders (35 papers). Marco Cipolli is often cited by papers focused on Blood disorders and treatments (41 papers), Cystic Fibrosis Research Advances (39 papers) and Immunodeficiency and Autoimmune Disorders (35 papers). Marco Cipolli collaborates with scholars based in Italy, United States and United Kingdom. Marco Cipolli's co-authors include Carla Colombo, K. De Boeck, Michael W. Konstan, J.S. Elborn, À. Munck, Gautham Marigowda, Michael Boyle, Félix Ratjen, Patrick A. Flume and Claire Wainwright and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Marco Cipolli

86 papers receiving 2.8k citations

Hit Papers

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Hom... 2015 2026 2018 2022 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
    2015 1.2k citations J.S. Elborn, Bonnie W. Ramsey et al. profile →

Peers

Marco Cipolli
Saleh Al‐Muhsen Saudi Arabia
Takuro Sakagami Japan
Farooq Rahman United Kingdom
William M. Hull United States
Maria M. Rodríguez United States
Bernt van den Blink Netherlands
Gitte Pedersen Denmark
Andrea Finocchi Italy
Etsuro Yamaguchi Japan
R G Crystal United States
Saleh Al‐Muhsen Saudi Arabia
Marco Cipolli
Citations per year, relative to Marco Cipolli Marco Cipolli (= 1×) peers Saleh Al‐Muhsen

Countries citing papers authored by Marco Cipolli

Since Specialization
Citations

This map shows the geographic impact of Marco Cipolli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Cipolli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Cipolli more than expected).

Fields of papers citing papers by Marco Cipolli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Cipolli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Cipolli. The network helps show where Marco Cipolli may publish in the future.

Co-authorship network of co-authors of Marco Cipolli

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Cipolli. A scholar is included among the top collaborators of Marco Cipolli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Cipolli. Marco Cipolli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Savi, Daniela, et al.. (2023). Long-term clinical outcomes of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis and advanced pulmonary disease. Respiratory Medicine. 219. 107406–107406. 7 indexed citations
3.
Bezzerri, Valentino, et al.. (2023). The pathogenic variant c.258+533_459+403del in SBDS gene is the commonest rare variant in Italy and shows a founder effect. Gene Reports. 31. 101775–101775. 1 indexed citations
4.
Costa, Enrico, Hendrika A. van den Ham, Marco Cipolli, et al.. (2023). Traits, trends and hits of orphan drug designations in cystic fibrosis. Journal of Cystic Fibrosis. 22(5). 949–957. 4 indexed citations
5.
Wilschanski, Michael, À. Munck, Marco Cipolli, et al.. (2023). ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis. Clinical Nutrition. 43(2). 413–445. 32 indexed citations
6.
Bezzerri, Valentino, Elisa Danese, Debora Olioso, et al.. (2023). Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation. International Journal of Molecular Sciences. 24(2). 908–908. 5 indexed citations
7.
8.
Bezzerri, Valentino, Laura Lentini, Vincenzo Cavalieri, et al.. (2022). Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome. Biomedicines. 10(4). 886–886. 15 indexed citations
9.
Costa, Enrico, et al.. (2022). The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis. Orphanet Journal of Rare Diseases. 17(1). 188–188. 39 indexed citations
10.
Alicandro, Gianfranco, Fabiana Ciciriello, Andrea Gramegna, et al.. (2022). Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes. Biomedicines. 10(11). 2771–2771. 2 indexed citations
11.
Cesaro, Simone, Jean Donadieu, Marco Cipolli, et al.. (2022). Stem Cell Transplantation in Patients Affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working Party. Transplantation and Cellular Therapy. 28(10). 637–649. 7 indexed citations
12.
Vella, Antonio, Elisabetta D’Aversa, Giulia Breveglieri, et al.. (2020). mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment. Cancers. 12(3). 597–597. 17 indexed citations
13.
Dřevı́nek, Pavel, Tacjana Pressler, Marco Cipolli, et al.. (2019). Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis. Journal of Cystic Fibrosis. 19(1). 99–107. 49 indexed citations
14.
Cipolli, Marco, Judith Fethney, Donna Waters, et al.. (2019). Occurrence, outcomes and predictors of portal hypertension in cystic fibrosis: A longitudinal prospective birth cohort study. Journal of Cystic Fibrosis. 19(3). 455–459. 15 indexed citations
15.
Cipolli, Marco, Gloria Tridello, Simone Cesaro, et al.. (2019). Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0–8 years old. BMJ Open. 9(1). e022617–e022617. 15 indexed citations
16.
Bezzerri, Valentino & Marco Cipolli. (2018). Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives. Molecular Diagnosis & Therapy. 23(2). 281–290. 56 indexed citations
17.
Bilton, Diana, T. Pressler, Isabelle Fajac, et al.. (2014). ANALYSIS OF LONG-TERM LIPOSOMAL AMIKACIN FOR INHALATION IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC INFECTION FROM PSEUDOMONAS AERUGINOSA. Pediatric Pulmonology. 49. 317–318. 6 indexed citations
18.
Bilton, Diana, T. Pressler, Marco Cipolli, et al.. (2013). PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA. Pediatric Pulmonology. 48. 290–290. 15 indexed citations
19.
Ooi, Chee Y., Ruslan Dorfman, Marco Cipolli, et al.. (2010). Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic Fibrosis. Gastroenterology. 140(1). 153–161. 170 indexed citations
20.
Piccoli, Anna, P. Capelli, A. Castagnini, et al.. (2002). [Latent celiac disease in subjects with serum anti-endomysial antibodies and normal intestinal biopsy].. PubMed. 24(5). 358–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saleh Al‐Muhsen Breakdown of academic impact, for papers by Takuro Sakagami Breakdown of academic impact, for papers by Farooq Rahman Breakdown of academic impact, for papers by William M. Hull Breakdown of academic impact, for papers by Maria M. Rodríguez Breakdown of academic impact, for papers by Bernt van den Blink Breakdown of academic impact, for papers by Gitte Pedersen Breakdown of academic impact, for papers by Andrea Finocchi Breakdown of academic impact, for papers by Etsuro Yamaguchi Breakdown of academic impact, for papers by R G Crystal
Rankless by CCL
2026